ResearcherUniversity of California Davis Medical CenterNo recent work listed

Primo N. Lara

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9512-0002; OpenAlex author ID A5075799959. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2015: 1 paper

Papers 1

Pharmacodynamic separation of gemcitabine and erlotinib in locally advanced or metastatic pancreatic cancer: therapeutic and biomarker results. Last author DOI 10.1007/s10147-014-0730-2 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Afsaneh Barzi · 1 shared paper, 2015 · strength 0.04
- Paper Pharmacodynamic separation of gemcitabine and erlotinib in locally advanced or metastatic pancreatic cancer: therapeuti… DOI 10.1007/s10147-014-0730-2 ↗
Thomas John Semrad · 1 shared paper, 2015 · strength 0.04
- Paper Pharmacodynamic separation of gemcitabine and erlotinib in locally advanced or metastatic pancreatic cancer: therapeuti… DOI 10.1007/s10147-014-0730-2 ↗
Edward Jae-Hoon Kim · 1 shared paper, 2015 · strength 0.04
- Paper Pharmacodynamic separation of gemcitabine and erlotinib in locally advanced or metastatic pancreatic cancer: therapeuti… DOI 10.1007/s10147-014-0730-2 ↗
Heinz‐Josef Lenz · 1 shared paper, 2015 · strength 0.04
- Paper Pharmacodynamic separation of gemcitabine and erlotinib in locally advanced or metastatic pancreatic cancer: therapeuti… DOI 10.1007/s10147-014-0730-2 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.